Prostate Cancer - Results from #26360

Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth - Abstract February 1, 2012

Modeling a lethal prostate cancer variant with small-cell carcinoma features - Abstract February 1, 2012

Research from the 2012 Genitourinary Cancers Symposium highlights new treatments, compares existing therapies for prostate cancer February 1, 2012

Chemoprevention of prostate cancer: Myths and realities - Abstract January 31, 2012

Targeted therapy in prostate cancer - Abstract January 31, 2012

A proposed new technique in prostate cancer tissue bio-banking: Our experience with a new protocol - Abstract January 31, 2012

Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of Medicare-age men - Abstract January 31, 2012

Oncologic outcomes of surgery in T3 prostate cancer: Experience of a single tertiary center - Abstract January 31, 2012

Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer - Abstract January 31, 2012

Prostate-specific antigen density as a powerful predictor of extracapsular extension and positive surgical margin in radical prostatectomy patients with prostate-specific antigen levels of less than 10 ng/ml - Abstract January 31, 2012

Are men who undergo radical prostatectomy with lower urinary tract symptoms at an increased risk for aggressive prostate cancer? - Abstract January 31, 2012

Fifth Joint Meeting of J-CaP and CaPSURE: Advancing the global understanding of prostate cancer and its management - Abstract January 31, 2012

MR-guided pulsed high intensity focused ultrasound enhancement of docetaxel combined with radiotherapy for prostate cancer treatment - Abstract January 31, 2012

Vanderbilt study finds prostate size may help predict cancer severity January 31, 2012

The HOPE fixation technique - a promising alternative to common prostate cancer biobanking approaches - Abstract January 30, 2012

18F-fluoride PET: Changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin) - Abstract January 30, 2012

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized p January 30, 2012

A direct comparison of the diagnostic accuracy of three prostate cancer nomograms designed to predict the likelihood of a positive initial transrectal biopsy - Abstract January 30, 2012

A stochastic model for survival of early prostate cancer with adjustments for leadtime, length bias, and over-detection - Abstract January 30, 2012

Weight change and prostate cancer incidence and mortality - Abstract January 30, 2012

Page 1319 of 1435